Literature DB >> 28079846

Patient confidence and quality of life in idiopathic pulmonary fibrosis and sarcoidosis.

Jalpa Kotecha1, Christopher Atkins, Andrew Wilson.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) and sarcoidosis impact significantly on health-related quality of life (HRQOL). There are few studies on the impact of patient confidence on HRQOL in these conditions.
OBJECTIVES: 1. To investigate whether patient confidence is associated with HRQOL, anxiety, depression, dyspnoea or fatigue. 2. To assess if patient confidence is associated with inpatient admissions, access to community healthcare and, for IPF patients, mortality and disease severity.
METHODS: Study participants self-completed seven questionnaires: Hospital Anxiety and Depression Scale, EuroQol 5D (EQ5D), King's Brief Interstitial Lung Disease questionnaire, St George's Respiratory Questionnaire, MRC dyspnoea scale, Fatigue Assessment Scale and a non-validated questionnaire assessing patient confidence, symptom duration and access to community healthcare. Lung function and follow-up data were collected from hospital electronic databases. Spearman's rank correlation coefficients were calculated to assess for correlation between patient confidence, questionnaire variables and inpatient admissions. Chi-square tests were performed to assess for association between patient confidence, mortality and disease severity.
RESULTS: 75 IPF patients and 69 sarcoidosis patients were recruited to the study. Patient confidence in IPF was significantly negatively correlated with depression and fatigue, and significantly positively correlated with EQ5D scores, but not healthcare outcomes. No associations were found between confidence and any of the variables assessed in sarcoidosis.
CONCLUSIONS: Lower levels of confidence in IPF patients are associated with higher levels of depression and fatigue and worse HRQOL. Efforts should be made to improve patient confidence to assess the impact on HRQOL.

Entities:  

Keywords:  Idiopathic pulmonary fibrosis, Sarcoidosis, Confidence, Health-related quality of life

Mesh:

Year:  2016        PMID: 28079846

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  5 in total

Review 1.  Idiopathic pulmonary fibrosis: a holistic approach to disease management in the antifibrotic age.

Authors:  Jonathon Shaw; Tracey Marshall; Helen Morris; Conal Hayton; Nazia Chaudhuri
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 2.  Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis.

Authors:  Catharina C Moor; Peter Heukels; Mirjam Kool; Marlies S Wijsenbeek
Journal:  Front Med (Lausanne)       Date:  2017-12-20

3.  The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.

Authors:  Alex Diamantopoulos; Emily Wright; Katerina Vlahopoulou; Laura Cornic; Nils Schoof; Toby M Maher
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

4.  Sarcoidosis and Work Participation: The Need to Develop a Disease-Specific Core Set for Assessment of Work Ability.

Authors:  C M R Hendriks; L A Saketkoo; M D P Elfferich; J De Vries; P A H M Wijnen; M Drent
Journal:  Lung       Date:  2019-05-17       Impact factor: 2.584

5.  Evaluation of health-related quality of life and the related factors in a group of Chinese patients with interstitial lung diseases.

Authors:  Xue-Yan Yuan; Hui Zhang; Li-Ru Huang; Fan Zhang; Xiao-Wen Sheng; Ai Cui
Journal:  PLoS One       Date:  2020-07-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.